Heron Therapeutics, Inc. (0J4V.L) LSE
0.50
-0.3347(-40.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 225.05M |
| Enterprise Value | 337.05M |
| P/E Ratio | -2.76 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.47 |
| Price/Book Ratio | 9.34 |
| Enterprise/Revenue | 1.24 |
| Enterprise/EBITDA | -9.07 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.21 |
| Operating Margin | -0.07 |
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -11.15 |
Income Statement
| Revenue | 154.9M |
| Revenue/Share | 0.79 |
| Gross Profit | 113.56M |
| EBITDA | -224,000 |
| Net Income | -20.2M |
| Diluted EPS | -0.12 |
Balance Sheet
| Total Cash | 44.78M |
| Total Cash/Share | 0.24 |
| Total Debt | 141.63M |
| Total Debt/Equity | 15.5 |
| Current Ratio | 2.53 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | -74.09 |
| 52-Week High | 3.2 |
| 52-Week Low | 0.5 |
| Moving Average 50 Days | 2.41 |
| Moving Average 200 Days | 1.57 |
Statistics
| Average Volume | 12,412 |
| Shares Outstanding | 175.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
